Clinical Trials Directory

Trials / Unknown

UnknownNCT02222792

BJI Inoplex 2 : Test for Diagnosis of Prosthetic Infections

Evaluation of the BJI Inoplex 2 Kit for the Multiplex Serological Diagnosis of Bone and Joint Prosthetic Device Infections

Status
Unknown
Phase
Study type
Observational
Enrollment
540 (estimated)
Sponsor
Diaxonhit · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A national, prospective, open-label, non-interventional, multicentre, controlled study designed to evaluate a diagnostic method in patients undergoing hip, knee or shoulder prosthetic removal regardless of whether or not infection is suspected. Serological test results will have no impact on the therapeutic approach. Study objective: To evaluate the diagnostic performance of an antibody detection kit for the serological diagnosis of bone and joint prosthetic device infections cause by Staphylococci, Streptococci, Propionibacterium acnes (P. acnes) and Gram-negative bacteria versus the reference method: the bacterial culture of deep intraoperative samples.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2014-05-01
Completion
2016-07-01
First posted
2014-08-21
Last updated
2014-08-21

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02222792. Inclusion in this directory is not an endorsement.

BJI Inoplex 2 : Test for Diagnosis of Prosthetic Infections (NCT02222792) · Clinical Trials Directory